JP2008266250A - Emulsifier form external preparation for skin - Google Patents
Emulsifier form external preparation for skin Download PDFInfo
- Publication number
- JP2008266250A JP2008266250A JP2007113743A JP2007113743A JP2008266250A JP 2008266250 A JP2008266250 A JP 2008266250A JP 2007113743 A JP2007113743 A JP 2007113743A JP 2007113743 A JP2007113743 A JP 2007113743A JP 2008266250 A JP2008266250 A JP 2008266250A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- carbonate
- emulsifier
- polyhydric alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- 239000003995 emulsifying agent Substances 0.000 title claims abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 27
- 239000000194 fatty acid Substances 0.000 claims abstract description 27
- 229930195729 fatty acid Natural products 0.000 claims abstract description 27
- 150000002148 esters Chemical class 0.000 claims abstract description 25
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 22
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 13
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims abstract description 11
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- OVVUWEAVYHWRLY-UHFFFAOYSA-N 1-hydroxypropan-2-yl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC(C)CO OVVUWEAVYHWRLY-UHFFFAOYSA-N 0.000 claims abstract 3
- -1 diester carbonate Chemical class 0.000 claims description 50
- 239000002537 cosmetic Substances 0.000 claims description 34
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 16
- 150000004650 carbonic acid diesters Chemical class 0.000 claims description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 11
- 150000005690 diesters Chemical class 0.000 abstract description 5
- 230000001804 emulsifying effect Effects 0.000 abstract description 4
- 239000003921 oil Substances 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 23
- 230000000694 effects Effects 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 239000003925 fat Substances 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 6
- 229960004063 propylene glycol Drugs 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (1R)-1,3-butanediol Natural products CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 3
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940031723 1,2-octanediol Drugs 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N 2-Methylheptane Chemical compound CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- OVBFMEVBMNZIBR-UHFFFAOYSA-N 2-methylvaleric acid Chemical compound CCCC(C)C(O)=O OVBFMEVBMNZIBR-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3-Methylheptane Chemical compound CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical group CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- ZZXUZKXVROWEIF-UHFFFAOYSA-N 1,2-butylene carbonate Chemical compound CCC1COC(=O)O1 ZZXUZKXVROWEIF-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- ZVYSYCLZXICWLH-UHFFFAOYSA-N 1,3-dioxetan-2-one Chemical compound O=C1OCO1 ZVYSYCLZXICWLH-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- ZFMMBNKWMKQSOL-UHFFFAOYSA-N 2-ethylhexanoic acid pentane Chemical compound CCCCC.C(C)C(C(=O)O)CCCC ZFMMBNKWMKQSOL-UHFFFAOYSA-N 0.000 description 1
- DMUXSGAKEXSNGN-UHFFFAOYSA-N 2-ethyloctanoic acid Chemical compound CCCCCCC(CC)C(O)=O DMUXSGAKEXSNGN-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- CVKMFSAVYPAZTQ-UHFFFAOYSA-N 2-methylhexanoic acid Chemical compound CCCCC(C)C(O)=O CVKMFSAVYPAZTQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- JKNNDGRRIOGKKO-UHFFFAOYSA-N 4-methyl-1,3-dioxepan-2-one Chemical compound CC1CCCOC(=O)O1 JKNNDGRRIOGKKO-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- FUFAPKOCRZYSHH-CVTBAMPXSA-N benzyl (1s,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylate Chemical compound O=C([C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)OCC1=CC=CC=C1 FUFAPKOCRZYSHH-CVTBAMPXSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JHXKRIRFYBPWGE-UHFFFAOYSA-K bismuth chloride Chemical compound Cl[Bi](Cl)Cl JHXKRIRFYBPWGE-UHFFFAOYSA-K 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940127292 dihydropyridine calcium channel blocker Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は皮膚外用剤に関し、更に詳細には乳化剤形の皮膚外用剤に関する。 The present invention relates to a skin external preparation, and more particularly to an emulsifier type skin external preparation.
メークアップ化粧料は、粉体の光学的効果を利用し、シミやソバカスなどの好ましくない色調特異部位をカバーし美しく装う化粧料である。化粧膜が崩れることによる、粉体の光学効果の変化はメークアップ化粧料に於いては最も回避すべき現象であり、この為メークアップ化粧料の化粧持ちの向上が種々検討され、幾多の化粧持ちに優れる化粧料が開発されている。この様な化粧料としては、例えば、疎水性の高い被膜を形成するポリマーを含有させた化粧料、3次元構造を有するシリコーンなどのように、皮膚との接着、密着性に優れた被膜に粉体を分散させたもの、油中水乳化剤形を採用し、耐水性の高い被膜を形成させる等の技術が例示できる。これらの新規技術の開発により、化粧持ちは向上されたが、その反面、化粧膜を除去するには、従来のクレンジングや洗顔などの方法では除去しにくくなりつつあり、この様な技術に対応した、除去化粧料の開発が望まれていた。 Make-up cosmetics are cosmetics that make use of the optical effect of powder to cover unpleasant color-specific parts such as spots and freckles and to be beautifully dressed. Changes in the optical effect of the powder due to the collapse of the cosmetic film is a phenomenon that should be avoided most in make-up cosmetics. Cosmetics with excellent durability have been developed. Examples of such cosmetics include cosmetics containing a polymer that forms a highly hydrophobic film, and powders that have excellent adhesion and adhesion to the skin, such as silicone having a three-dimensional structure. Examples thereof include a technique in which a body is dispersed, a water-in-oil emulsifier form, and a film having high water resistance is formed. With the development of these new technologies, makeup lasting has been improved, but on the other hand, it is becoming difficult to remove the cosmetic film by conventional cleansing and facial cleansing methods. The development of removal cosmetics has been desired.
この様な落としにくい化粧膜の除去には、ネイルカラーの除去技術である、炭酸エチレン、炭酸プロピレンなどの炭酸ジエステル、短鎖分岐脂肪酸の多価アルコールエステルなどの溶剤性の油脂を利用する方法(例えば、特許文献1、特許文献2、特許文献3、特許文献4を参照)が考えられるが、粉体のような両親媒性の成分に対しては、この様な溶剤性油脂によっても、粉体類或いは被膜が皮膚上に残存してしまう場合が存し、この原因は親水性の成分の不足によるものと考えられた。この様な状況は二酸化チタンなどの紫外線遮蔽剤を含有する紫外線ケア用の化粧料に於いても、光学効果を紫外線防護効果に読み替えれば同様の状況であると言える。 For removal of such difficult-to-remove cosmetic films, a method using a solvent-based oil or fat such as a carbonic acid diester such as ethylene carbonate or propylene carbonate or a polyhydric alcohol ester of a short-chain branched fatty acid, which is a nail color removal technique ( For example, see Patent Document 1, Patent Document 2, Patent Document 3, and Patent Document 4), but for amphiphilic components such as powder, such solvent oils and fats can also be used. There were cases where the body or film remained on the skin, and this was thought to be due to a lack of hydrophilic components. Such a situation can be said to be the same situation in an ultraviolet care cosmetic containing an ultraviolet shielding agent such as titanium dioxide if the optical effect is read as an ultraviolet protective effect.
親油性物質と親水性物質とをともに可溶化、分散する技術としては、乳化物を媒体に使用する技術が存するが、前記溶剤性油脂は、乳化のための必須条件である界面活性剤の界面への配向を、油相に界面活性剤を溶解させることにより阻害するため、容易には乳化できない問題が存した。 As a technique for solubilizing and dispersing both a lipophilic substance and a hydrophilic substance, there is a technique in which an emulsion is used as a medium. However, the solvent-based fat or oil is an indispensable condition for emulsification. There was a problem that it could not be easily emulsified because the orientation of the polymer was inhibited by dissolving the surfactant in the oil phase.
視点を変えて、「溶剤性油脂」を乳化した剤形は、ポリエンマクロライド系抗生物質、ジヒドロピリジン系カルシウム拮抗剤等の水難溶性或いは油脂難溶性薬剤の経皮投与のためのベヒクルとして好適とも考えられ、この点からも溶剤性油脂を乳化した外用剤形の開発が望まれていると言える。 From a different viewpoint, the dosage form emulsified with “solvent oils and fats” is also considered suitable as a vehicle for transdermal administration of poorly water-soluble or fat-soluble oils such as polyene macrolide antibiotics and dihydropyridine calcium antagonists. From this point of view, it can be said that development of an external dosage form emulsified with solvent-based fats and oils is desired.
一方、アルキル変性カルボキシビニルポリマー及び/又はその塩は、乳化作用を有する増粘剤として知られており、化粧料などの皮膚外用剤の分野に於いて、水中油乳化剤形で使用されている(例えば、特許文献5、特許文献6、特許文献7、特許文献8を参照)が、前記溶剤性油脂の乳化の為に使用された例はないし、かかる成分を利用することにより、溶剤性油脂の乳化がなしうることも全く知られていない。 On the other hand, alkyl-modified carboxyvinyl polymers and / or salts thereof are known as thickeners having an emulsifying action, and are used in the form of oil-in-water emulsifiers in the field of skin external preparations such as cosmetics ( For example, Patent Document 5, Patent Document 6, Patent Document 7, and Patent Document 8) are not used for emulsification of the solvent-based fats and oils. It is not known at all that emulsification can be achieved.
本発明は、この様な状況下為されたものであり、炭酸エチレン、炭酸プロピレンなどの炭酸ジエステル、短鎖分岐脂肪酸の多価アルコールエステルなどの溶剤性の油脂を安定に乳化する技術を提供することを課題とする。 The present invention has been made under such circumstances, and provides a technique for stably emulsifying solvent-based fats and oils such as carbonic acid diesters such as ethylene carbonate and propylene carbonate, and polyhydric alcohol esters of short chain branched fatty acids. This is the issue.
この様な状況に鑑みて、炭酸エチレン、炭酸プロピレンなどの炭酸ジエステル、短鎖分岐脂肪酸の多価アルコールエステルなどの溶剤性の油脂を安定に乳化する技術を求めて、鋭意研究を重ねた結果、1)アルキル変性カルボキシビニルポリマー及び/又はその塩を用いることにより、前記溶剤性の油脂が乳化できることを見いだし、発明を完成させるに至った。即ち、本発明は以下に示す通りである。
(1)1)アルキル変性カルボキシビニルポリマー及び/又はその塩と、2)炭酸ジエステル及び分岐脂肪酸(炭素数4〜10)の多価アルコールエステルから選択される1種乃至は2種以上とを含有する乳化剤形の皮膚外用剤。
(2)前記炭酸ジエステル及び炭素数4〜10の分岐脂肪酸の多価アルコールエステルから選択される1種乃至は2種以上は、炭酸エチレン、炭酸プロピレン、炭酸ジカプリル、プロピレングリコールモノ−2−エチルヘキサン酸エステル及びエチレングリコールジ−2−エチルヘキサン酸エステルから選択される1種乃至は2種以上であることを特徴とする、(1)に記載の乳化剤形の皮膚外用剤。
(3)前記炭酸ジエステル及び炭素数4〜10の分岐脂肪酸の多価アルコールエステルから選択される1種乃至は2種以上は、炭酸エチレン、炭酸プロピレン、炭酸ジカプリル、プロピレングリコールモノ−2−エチルヘキサン酸エステル及びエチレングリコールジ−2−エチルヘキサン酸エステルから選択される1種乃至は2種以上の含有量は、総量で、皮膚外用剤全量に対して、5〜30質量%であることを特徴とする、(1)又は(2)に記載の乳化剤形の皮膚外用剤。
(4)更に、抗菌性多価アルコールを含有することを特徴とする、(1)〜(3)何れか1項に記載の乳化剤形の皮膚外用剤。
(5)クレンジング化粧料であることを特徴とする(1)〜(4)何れか1項に記載の乳化剤形の皮膚外用剤。
(6)ウォッシュオフ態様で使用されるべきものであることを特徴とする、(5)に記載の乳化剤形の皮膚外用剤。
In view of such circumstances, as a result of earnest research, seeking a technique for stably emulsifying solvent-based fats and oils such as carbonic acid diesters such as ethylene carbonate and propylene carbonate, polyhydric alcohol esters of short-chain branched fatty acids, 1) By using an alkyl-modified carboxyvinyl polymer and / or a salt thereof, it was found that the solvent-based fats and oils can be emulsified, and the present invention has been completed. That is, the present invention is as follows.
(1) 1) Alkyl-modified carboxyvinyl polymer and / or salt thereof, and 2) 1 type or 2 types or more selected from carbonic acid diesters and polyhydric alcohol esters of branched fatty acids (4 to 10 carbon atoms) Emulsifier type skin external preparation.
(2) One type or two or more types selected from the carbonic acid diester and a polyhydric alcohol ester of a branched fatty acid having 4 to 10 carbon atoms are ethylene carbonate, propylene carbonate, dicapryl carbonate, propylene glycol mono-2-ethylhexane. The emulsifier-type skin external preparation according to (1), characterized in that it is one or more selected from acid esters and ethylene glycol di-2-ethylhexanoate.
(3) One type or two or more types selected from the carbonic acid diester and a polyhydric alcohol ester of a branched fatty acid having 4 to 10 carbon atoms are ethylene carbonate, propylene carbonate, dicapryl carbonate, propylene glycol mono-2-ethylhexane. The content of one or more selected from acid esters and ethylene glycol di-2-ethylhexanoate is 5 to 30% by mass based on the total amount of the external preparation for skin, based on the total amount. The skin external preparation in the form of an emulsifier according to (1) or (2).
(4) The emulsifier-type skin external preparation according to any one of (1) to (3), further comprising an antibacterial polyhydric alcohol.
(5) The skin external preparation in the form of an emulsifier according to any one of (1) to (4), which is a cleansing cosmetic.
(6) The skin external preparation in the form of an emulsifier according to (5), which should be used in a wash-off mode.
本発明によれば、炭酸エチレン、炭酸プロピレンなどの炭酸ジエステル、短鎖分岐脂肪酸の多価アルコールエステルなどの溶剤性の油脂を安定に乳化する技術を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the technique which emulsifies solvent fats and oils, such as carbonic acid diesters, such as ethylene carbonate and a propylene carbonate, the polyhydric alcohol ester of a short chain branched fatty acid, can be provided.
(1)本発明の皮膚外用剤の必須成分である溶剤性の油脂
本発明の皮膚外用剤は、炭酸ジエステル及び分岐脂肪酸(炭素数4〜10)の多価アルコールエステルから選択される1種乃至は2種以上を含有し、乳化剤形であることを特徴とする。ここで、炭酸ジエステル及び分岐脂肪酸(炭素数4〜10)の多価アルコールエステルから選択される1種乃至は2種以上は、化粧料などの皮膚外用剤に於いて、皮膚を滑らかにし、且つ、閉塞性によって皮膚を保湿する油脂としての作用を有しながら、ポリマー、コポリマー、高融点ワックスなどの難溶性の成分を溶かす作用に優れる溶剤としての性格も併せ持つ。かかる成分は、コポリマー類を含有する化粧料によって、塗布後に皮膚上の形成される、除去しにくい化粧膜の骨格部分となっているコポリマー類を溶解せしめ、落としやすくさせる効果を有する。この様な炭酸ジエステル及び分岐脂肪酸(炭素数4〜10)の多価アルコールエステルから選択される1種乃至は2種以上の具体例を例示するならば、炭酸ジエステルであれば、炭酸メチレン、炭酸エチレン、炭酸プロピレン、炭酸ブチレンなどの炭素数1〜4のものの環状ジエステル乃至は炭酸ジカプリン、炭酸ジカプリルなどの炭素数6〜12の中鎖アルコールのジエステルが好ましい。特に好ましいものは、炭酸エチレン、炭酸プロピレン、炭酸ジカプリルである。又、分岐脂肪酸(炭素数4〜10)の多価アルコールエステルとしては、イソブタン酸、2−メチルプロパン酸、2−メチルペンタン酸、2−メチルヘキサン酸、2−エチルヘキサン酸、2−メチルヘプタン酸、2−エチルオクタン酸などの、エチレングリコールエステル、プロピレングリコールエステル、1,3−ブタンジオールエステル、グリセロールエステルなどが好適に例示でき、特にプロピレングリコールエステル及びエチレングリコールエステルが好ましい。エステルとしては、ジエステルでも、モノエステルでも特段の制限は無い。特に好ましい具体例としては、2−エチルヘキサン酸モノプロピレングリコールエステル、2−エチルヘキサン酸ジプロピレングリコールエステル、2−エチルヘキサン酸モノエチレングリコールエステル、2-エチルヘキサン酸エチレングリコールジエステル、2−エチルヘキサン酸モノグリセリルエステルなどが挙げられ、中でも2−エチルヘキサン酸モノプロピレングリコールエステル、2-エチルヘキサン酸エチレングリコールジエステルが特に好適に例示できる。これらのエステルに於いては少なくとも1個の水酸基を有することが好ましい。特に好ましくは多価アルコールのモノエステルの形態を取ることである。かかる成分は唯一種を含有することも出来るし、二種以上を組み合わせて含有させることも出来る。前記の溶剤効果と、油脂効果を同時に発現するためには、かかる成分は、総量で、皮膚外用剤全量に対して、5〜30質量%であることが好ましく、より好ましくは8〜25質量%であり、更に好ましくは、9〜22質量%である。これは少なすぎると前記溶剤効果を奏しない場合が存し、多すぎると本発明の効果である乳化剤形の乳化を損なう場合が存するからである。
(1) Solvent-based fats and oils that are essential components of the external preparation for skin of the present invention The external skin preparation of the present invention is selected from a carbonic acid diester and a polyhydric alcohol ester of a branched fatty acid (4 to 10 carbon atoms). Contains two or more, and is characterized by being in an emulsifier form. Here, one or more selected from carbonic acid diesters and polyhydric alcohol esters of branched fatty acids (4 to 10 carbon atoms) are used in skin external preparations such as cosmetics to smooth the skin, and In addition, it has an action as an oil and fat that moisturizes the skin due to its occlusive property, and also has a character as a solvent that is excellent in the action of dissolving hardly soluble components such as polymers, copolymers, and high melting point waxes. Such a component has an effect of dissolving and facilitating the removal of the copolymers which are formed on the skin after application and are a skeleton part of the cosmetic film which is difficult to remove by the cosmetic containing the copolymers. If one or more specific examples selected from such carbonic acid diesters and polyhydric alcohol esters of branched fatty acids (4 to 10 carbon atoms) are illustrated, methylene carbonate, carbonic acid Cyclic diesters having 1 to 4 carbon atoms such as ethylene, propylene carbonate and butylene carbonate or diesters of medium chain alcohols having 6 to 12 carbon atoms such as dicaprin carbonate and dicapryl carbonate are preferred. Particularly preferred are ethylene carbonate, propylene carbonate, and dicapryl carbonate. In addition, as polyhydric alcohol esters of branched fatty acids (4 to 10 carbon atoms), isobutanoic acid, 2-methylpropanoic acid, 2-methylpentanoic acid, 2-methylhexanoic acid, 2-ethylhexanoic acid, 2-methylheptane Examples thereof include ethylene glycol ester, propylene glycol ester, 1,3-butanediol ester, glycerol ester and the like such as acid and 2-ethyloctanoic acid, and propylene glycol ester and ethylene glycol ester are particularly preferable. There are no particular restrictions on the ester, whether it is a diester or a monoester. Particularly preferred specific examples include 2-ethylhexanoic acid monopropylene glycol ester, 2-ethylhexanoic acid dipropylene glycol ester, 2-ethylhexanoic acid monoethylene glycol ester, 2-ethylhexanoic acid ethylene glycol diester, 2-ethylhexane. Acid monoglyceryl ester and the like can be mentioned, among which 2-ethylhexanoic acid monopropylene glycol ester and 2-ethylhexanoic acid ethylene glycol diester are particularly preferred. These esters preferably have at least one hydroxyl group. Particularly preferred is the form of a monoester of a polyhydric alcohol. Such a component may contain only one species or may contain two or more species in combination. In order to express the solvent effect and the oil and fat effect at the same time, the total amount of such components is preferably 5 to 30% by mass, more preferably 8 to 25% by mass, based on the total amount of the external preparation for skin. More preferably, it is 9-22 mass%. This is because if the amount is too small, the solvent effect may not be achieved, and if the amount is too large, emulsification of the emulsifier form, which is the effect of the present invention, may be impaired.
(2)本発明の皮膚外用剤の必須成分であるアルキル変性カルボキシビニルポリマー
本発明の皮膚外用剤は、必須成分として、アルキル変性カルボキシビニルポリマー及び/又はその塩を含有することを特徴とする。これらの塩としては、皮膚外用剤で使用されるものであれば、特段の限定無く使用でき、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム塩、マグネシウム塩等のアルカリ土類金属塩、アンモニウム塩、トリエチルアミン塩、トリエタノールアミン塩、モノエタノールアミン塩等の有機アミン塩、リジン塩、アルギン酸塩等の塩基性アミノ酸塩等が好適に例示できる。特に好ましいものはアルカリ金属塩であり、中でもナトリウム塩或いはカリウム塩が特に好ましい。また、前記アルキル変性カルボキシビニルポリマーを構成するアルキル基としては、炭素数10〜30のものが好ましく、炭素数に分布のあるアルキル基の交合した誘導体を用いることが好ましい。この様なアルキル変性カルボキシビニルポリマーには既に市販されている原料が存し、この様な市販品を購入して利用することも出来る。好ましい市販品としては、例えば、BFグッドリッチ社製の「カーボポール1382」、「ペムレンTR−1」、「ペムレンTR−2」等が例示できる。かかる成分は、本発明の皮膚外用剤に於いては、前記溶剤性の油脂を含む油相を、油滴として、安定に水相中に分散せしめる作用を有する。この様な作用を奏するためには、かかる成分を総量で皮膚外用剤全量に対して、0.1〜1質量%含有させることが好ましく、より好ましくは、0.2〜0.5質量%である。
(2) Alkyl-modified carboxyvinyl polymer which is an essential component of the skin external preparation of the present invention The skin external preparation of the present invention contains an alkyl-modified carboxyvinyl polymer and / or a salt thereof as an essential component. These salts can be used without any particular limitation as long as they are used in skin external preparations, for example, alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts. Preferred examples include organic amine salts such as ammonium salt, triethylamine salt, triethanolamine salt, and monoethanolamine salt, and basic amino acid salts such as lysine salt and alginate. Particularly preferred are alkali metal salts, with sodium or potassium salts being particularly preferred. Moreover, as an alkyl group which comprises the said alkyl modified carboxy vinyl polymer, a C10-C30 thing is preferable and it is preferable to use the derivative | guide_body which the alkyl group with a carbon number distribution combined. Such alkyl-modified carboxyvinyl polymer has raw materials already on the market, and such commercial products can be purchased and used. Examples of preferable commercial products include “Carbopol 1382”, “Pemlen TR-1”, “Pemlen TR-2” and the like manufactured by BF Goodrich. In the external preparation for skin according to the present invention, such a component has an action of stably dispersing the oil phase containing the solvent-based oil and fat as oil droplets in the aqueous phase. In order to exert such an action, it is preferable to contain 0.1 to 1% by mass of the total amount of such components with respect to the total amount of the external preparation for skin, more preferably 0.2 to 0.5% by mass. is there.
(3)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分を含有し、乳化剤形を取ることを特徴とする。前記乳化剤形としては、特段の限定は存しないが、水中油乳化剤形であることが好ましい。ここで、本発明に言う、水中油乳化剤形とは、最外相が水相であって、内相に油滴相を有する乳化剤形の総称であり、水中油中水剤形などの複合乳化剤形も、前記条件を充足する限りに於いては包含する。
(3) External preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing the essential components and taking an emulsifier form. The emulsifier form is not particularly limited, but is preferably an oil-in-water emulsifier form. Here, the oil-in-water emulsifier form referred to in the present invention is a general term for an emulsifier form in which the outermost phase is an aqueous phase and has an oil droplet phase in the inner phase, and a composite emulsifier form such as a water-in-oil-in-water form. As long as the above conditions are satisfied.
本発明の皮膚外用剤においては、かかる必須成分以外に、通常皮膚外用剤で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。 In the external preparation for skin of the present invention, optional components usually used in external preparations for skin can be contained in addition to the essential components. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oil, wax, oils such as beeswax, owl, hardened castor oil, beeswax, candelilla wax, carnauba wax, botarou, lanolin, reduced lanolin, hard lanolin, jojoba wax , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, neopentyl glycol dicaprate, glycerin di-2-heptylundecanoate, glycerin tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetra-2- Synthetic ester oils such as ethylhexanoic acid pentane erythritol; chains such as dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane Cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane; modified polysiloxanes such as amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, and fluorine-modified polysiloxane Oils such as silicone oils; fatty acid soap (sodium laurate, sodium palmitate, etc.), anionic surfactants such as potassium lauryl sulfate, alkylsulfuric triethanolamine ether; stearyltrimethylammonium chloride, benzalkonium chloride, Cationic surfactants such as laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyl) Roxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), and amphoteric surfactants such as acylmethyl taurine; sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.) ), Glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, glycerin alkyl ether, POE sorbitan fatty acid esters (POE sorbitan monooleate, monostearin) Acid polyoxyethylene sorbitan, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisosteale) POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE -POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid esters, alkyl glucosides, etc. Nonionic surfactants: polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglyceride Polyhydric alcohols such as sodium, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol; sodium pyrrolidone carboxylate, lactic acid, sodium lactate, etc. Moisturizing ingredients; powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc., whose surface may be treated; Bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide inorganic pigments; surface may be treated, mica titanium, fish phosphorus foil, oxy Pearl agents such as bismuth chloride; red 202, red 228, red 226, yellow 4 and blue 40 which may be raked No. 4, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204 Organic pigments such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer, etc .; paraaminobenzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; Cinnamic acid UV absorbers; benzophenone UV absorbers; sugar UV absorbers; 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 4-methoxy-4′-t-butyldi UV absorbers such as benzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or a derivative thereof; Mineral B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or derivatives thereof, vitamin B12 such as vitamin B12, vitamin B15 or derivatives thereof; α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate Preferred examples include vitamins such as vitamin E, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, and the like; and antibacterial agents such as phenoxyethanol.
前記の任意成分の中で特に好ましいものは、非イオン界面活性剤であり、中でも、親油性の界面活性剤であって、乳化状態に於いて構造形成性に優れるもの好ましく、かかる非イオン界面活性剤としては、ソルビタンステアリン酸エステル、グリセリンモノステアリン酸エステルなどが特に好適に例示できる。かかる成分の好ましい含有量は0.1〜5質量%であり、より好ましくは0.2〜3質量%である。かかる成分を加えることにより、皮膚との接着性に優れるようになる。 Among the above optional components, nonionic surfactants are particularly preferable, and among them, lipophilic surfactants that are excellent in structure formation in an emulsified state are preferable. As the agent, sorbitan stearate ester, glycerin monostearate ester and the like can be particularly preferably exemplified. The preferable content of such components is 0.1 to 5% by mass, and more preferably 0.2 to 3% by mass. By adding such a component, the adhesiveness with the skin becomes excellent.
本発明の皮膚外用剤に於いては、溶剤性の油脂によって、パラベン類が油相中に取り込まれやすいことから、パラベン類に代わる防腐手段を用いることが好ましい。この様な防腐手段としては、例えば、イソプレングリコール、ヘキシレングリコール、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール、1,2−デカンジオール、より好ましくは、1,2−ペンタンジオール乃至は1,2−ヘキサンジオールなどの抗菌性多価アルコールを2〜6質量%、より好ましくは3〜5質量%含有させることが好適に例示できる。更に、フェノキシエタノールを0.1〜1質量%、より好ましくは、0.2〜0.8質量%含有させると、防腐力が更に向上するので好ましい。油相に取り込まれやすいブチルパラベンは、配合効果が得られない場合が存するので含有しない方が好ましい。 In the external preparation for skin of the present invention, parabens are easily taken into the oil phase by solvent-based oils and fats, and therefore it is preferable to use an antiseptic means instead of parabens. Examples of such preservatives include isoprene glycol, hexylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, and more preferably 1 Suitable examples include 2 to 6% by mass, more preferably 3 to 5% by mass of an antibacterial polyhydric alcohol such as 1,2-pentanediol or 1,2-hexanediol. Furthermore, it is preferable to contain 0.1 to 1% by mass, more preferably 0.2 to 0.8% by mass of phenoxyethanol, since the antiseptic power is further improved. It is preferable not to contain butylparaben which is easily incorporated into the oil phase because there are cases where the blending effect cannot be obtained.
本発明の皮膚外用剤は、皮膚の外用で適用されるものであれば特段の限定無く適用することが可能であり、例えば、保湿クリーム、保湿乳液、美白クリーム、マッサージクリーム、栄養乳液、栄養クリーム、クレンジングクリームなどの化粧料、抗真菌皮膚外用医薬、抗炎症皮膚外用医薬、ステロイド皮膚外用医薬、殺菌創傷治癒皮膚外用医薬などの皮膚外用医薬などが特に好適に例示できる。特に好ましいものは、前記溶剤性の油脂の溶剤効果と、水性成分の水性成分包含、除去効果をともに利用できる、クレンジング化粧料である。クレンジング化粧料に於いては、前記の如く、HLB10以上の非イオン界面活性剤を含有させて、ウォッシュオフ効果を持たせることが好ましい。又、かかるクレンジング化粧料の、落とすべき対象としては、ポリマー乃至はコポリマーを含有し、且つ、粉体とワックスなどの水難溶性成分を含む蓋然性の高い化粧料であり、加えて、アイライナーやマスカラなどのように、センシチブな部位の近傍に適用する化粧料である。この様な化粧料に対しては、本発明の皮膚外用剤の効果が特に顕著に発現される。 The external preparation for skin of the present invention can be applied without particular limitation as long as it is applied for external use on the skin. For example, moisturizing cream, moisturizing milk, whitening cream, massage cream, nutritional milk, nutritional cream Cosmetic preparations such as cleansing creams, antifungal skin external medicines, anti-inflammatory skin external medicines, steroid skin external medicines, sterilized wound healing skin external medicines and the like can be particularly preferably exemplified. Particularly preferred is a cleansing cosmetic that can utilize both the solvent effect of the solvent-based fats and oils and the effect of including and removing the aqueous component. In cleansing cosmetics, as described above, it is preferable to include a nonionic surfactant having an HLB of 10 or more to provide a wash-off effect. In addition, the cleansing cosmetics to be removed include polymers or copolymers, and cosmetics having a high probability of containing poorly water-soluble components such as powders and waxes. In addition, eyeliner and mascara It is a cosmetic applied in the vicinity of a sensitive part. For such cosmetics, the effect of the external preparation for skin of the present invention is particularly prominent.
又、本発明の皮膚外用剤は、難溶性の薬剤を有効成分として含有する、皮膚外用医薬に適用することも好ましい。これは、難溶性薬剤の可溶化と経皮吸収に本発明の皮膚外用剤の特性を生かせるからである。この様な難溶性薬剤としては、例えば、ポリエンマクロライドのような抗生物質、ステロイド、ウルソール酸、オレアノール酸などのトリテルペン酸、ウルソール酸ステアリル、ウルソール酸ベンジルなどのトリテルペン酸のエステル、ウルソール酸グルコシドなどのトリテルペン酸配糖体、スフィンゴシン、スフィンゴ糖脂質、スフィンゴリン脂質、スチグマスタノールなどのフィトステロール、スチグマスタノールグルコシド、スチグマスタノールマルトシドなどのフィトステロールの配糖体などが好適に例示できる。かかる難溶性の薬剤の好ましい含有量は、0.01〜10質量%である。 In addition, the external preparation for skin of the present invention is also preferably applied to an external preparation for skin containing a hardly soluble drug as an active ingredient. This is because the characteristics of the external preparation for skin of the present invention can be utilized for solubilization and percutaneous absorption of poorly soluble drugs. Examples of such poorly soluble drugs include antibiotics such as polyene macrolide, triterpenic acids such as steroids, ursolic acid and oleanolic acid, esters of triterpenic acids such as stearyl ursolate and benzyl ursolate, and ursolic acid glucoside. Preferable examples include phytosterols such as triterpenic acid glycosides, sphingosine, sphingoglycolipids, sphingophospholipids, and stigmasteranol, and phytosterol glycosides such as stigmasteranol glucoside and stigmasteranol maltoside. The preferable content of such a poorly soluble drug is 0.01 to 10% by mass.
本発明の皮膚外用剤は、前記の成分を常法に従って処理することにより、製造することが出来る。以下に、実施例を挙げて、本発明について更に詳細に説明を加えるが、本発明が、かかる実施例にのみ限定されないのは言うまでもない。 The external preparation for skin of the present invention can be produced by treating the above components according to a conventional method. Hereinafter, the present invention will be described in more detail with reference to examples, but it goes without saying that the present invention is not limited to such examples.
以下に示す処方に従って、本発明の皮膚外用剤である、クレンジング化粧料1を作製した。即ち、イ、ロ、ハの成分をそれぞれ80℃に加温し、攪拌下イにロを加え、中和して、しかる後に攪拌下ハの成分を徐々に加え乳化し、攪拌冷却し、クレンジング化粧料1を得た。同様に操作して、「ペムレンTR−2」をPOE(25)ステアリン酸に置換した比較例1、2−エチルヘキサン酸プロピレングリコールモノエステルを2−エチルヘキサン酸セチルに置換した比較例2、2−エチルヘキサン酸プロピレングリコールモノエステルを2−エチルヘキサン酸セチルに、且つ、「ペムレンTR−2」をPOE(25)ステアリン酸に置換した比較例3も同様に作製してみたところ、比較例1は製造直後に分離しており、乳化物が得られなかった。 According to the formulation shown below, cleansing cosmetic 1 which is a skin external preparation of the present invention was produced. In other words, the components of A, B, and C are each heated to 80 ° C., and the mixture is neutralized by adding B to the mixture under stirring, and then the components of C are gradually added and emulsified with stirring, cooled with stirring, and cleaned. Cosmetic 1 was obtained. In the same manner, Comparative Example 2 in which “Pemlen TR-2” was substituted with POE (25) stearic acid 1,2-ethylhexanoic acid propylene glycol monoester was substituted with cetyl 2-ethylhexanoate Comparative Examples 2, 2 When Comparative Example 3 in which propylene glycol monoester of ethylhexanoic acid was substituted with cetyl 2-ethylhexanoate and “Pemlen TR-2” was substituted with POE (25) stearic acid was also prepared in the same manner, Comparative Example 1 Was separated immediately after production, and no emulsion was obtained.
<試験例1>
クレンジング化粧料1、比較例2、比較例3についてクレンジング効果を比較した。方法は型どり用のシリコーンゴムを用いて上瞼の形状を写し取った型を4つ用意し、この瞼の型の淵の部位に下記の表2に処方を示すアイライナーを塗布し、乾燥させた後、3つについて、これを電子天秤にのせ、それぞれクレンジング1、比較例2、比較例3を含浸した綿棒で15〜25gに圧着力がおさまるように20回擦過し、しかる後に流水下に30分さらし、「キムワイプ」で水分を除去し、拡大ビデオで画像として取込、塗布部位について、「フォトショップ」でGBRに分解し、Bチャンネル画像を作製し、総輝度を算出し、これを比較した。クレンジング操作を行わなかったものを無処置とし、同様にBチャンネル画像の総輝度を求めた。即ち、アイライナーが残存していれば総輝度は大きくなり、アイライナーが除去されれば総輝度は小さくなる。下記の表3に処置の総輝度を無処置の総輝度で除した値である、Bチャンネル総輝度比を示す。これより本発明の皮膚外用剤であるクレンジング化粧料は、細かい起伏を有し、力をかけにくい部位に塗布された、コポリマーやワックスを配合した、例えば、アイライナーなどのアイメークアップ化粧料などのメークアップ化粧料を除去する作用に優れることがわかる。
<Test Example 1>
The cleansing effect was compared for cleansing cosmetic 1, comparative example 2, and comparative example 3. In this method, four molds were prepared by copying the shape of the upper eyelid using silicone rubber for shaping, and the eyeliner shown in Table 2 below was applied to the eyelid portion of the eyelid mold and dried. After that, three of these were placed on an electronic balance and rubbed 20 times with a cotton swab impregnated with cleansing 1, comparative example 2 and comparative example 3 so that the crimping force was reduced to 15 to 25 g. Exposure, remove moisture with "Kimwipe", capture as an image with enlarged video, disassemble into GBR with "Photoshop" for the application site, create a B channel image, calculate total luminance, compare did. No cleansing operation was performed, and the total luminance of the B channel image was obtained in the same manner. That is, if the eyeliner remains, the total luminance increases, and if the eyeliner is removed, the total luminance decreases. Table 3 below shows the B channel total luminance ratio, which is a value obtained by dividing the total luminance of treatment by the total luminance of no treatment. As a result, the cleansing cosmetic that is an external preparation for skin of the present invention has a fine undulation and is applied to a site where it is difficult to apply force, and contains a copolymer or wax, such as an eye makeup cosmetic such as an eyeliner. It turns out that it is excellent in the effect | action which removes makeup cosmetics.
以下に示す処方に従って、実施例1と同様に本発明の皮膚外用剤である、クレンジング化粧料2を作製した。試験例1での評価結果はBチャンネル総輝度比にして0.15であり、同様の効果が認められた。 According to the formulation shown below, a cleansing cosmetic 2 that is a skin external preparation of the present invention was prepared in the same manner as in Example 1. The evaluation result in Test Example 1 was 0.15 in terms of the B channel total luminance ratio, and the same effect was recognized.
以下に示す処方に従って、実施例1と同様に本発明の皮膚外用剤である、クレンジング化粧料3〜5を作製した。試験例1での評価結果は表6に示す。同様の効果が確認された。 According to the prescription shown below, cleansing cosmetics 3 to 5, which are skin external preparations of the present invention, were prepared in the same manner as in Example 1. Evaluation results in Test Example 1 are shown in Table 6. Similar effects were confirmed.
下記に示す処方に従って、難溶性有効成分を含有するクリーム6〜14を作製した。何れの難溶性成分も結晶を析出することなく配合された。これより、本発明の皮膚外用剤は皮膚外用医薬品の基剤としても優れた性質を有していることがわかる。 Creams 6 to 14 containing a sparingly soluble active ingredient were prepared according to the formulation shown below. Any poorly soluble component was blended without precipitating crystals. From this, it can be seen that the external preparation for skin of the present invention has excellent properties as a base for external preparations for skin.
以下に示す処方に従って、実施例1と同様に本発明の皮膚外用剤である、クレンジング化粧料15を作製した。試験例1での評価結果はBチャンネル総輝度比にして0.13であり、同様の効果が認められた。 According to the formulation shown below, a cleansing cosmetic 15 that is an external preparation for skin of the present invention was prepared in the same manner as in Example 1. The evaluation result in Test Example 1 was 0.13 as the B channel total luminance ratio, and the same effect was recognized.
下記に示す処方に従って、難溶性有効成分を含有するクリーム16〜24を作製した。何れの難溶性成分も結晶を析出することなく配合された。これより、本発明の皮膚外用剤は皮膚外用医薬品の基剤としても優れた性質を有していることがわかる。 According to the formulation shown below, creams 16 to 24 containing hardly soluble active ingredients were prepared. Any poorly soluble component was blended without precipitating crystals. From this, it can be seen that the external preparation for skin of the present invention has excellent properties as a base for external preparations for skin.
本発明は、クレンジング化粧料や難溶性有効成分含有皮膚外用剤など、皮膚外用剤全般に応用することが出来る。 The present invention can be applied to skin external preparations in general, such as cleansing cosmetics and skin external preparations containing hardly soluble active ingredients.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007113743A JP5069940B2 (en) | 2007-04-24 | 2007-04-24 | Emulsifier type skin external preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007113743A JP5069940B2 (en) | 2007-04-24 | 2007-04-24 | Emulsifier type skin external preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008266250A true JP2008266250A (en) | 2008-11-06 |
JP2008266250A5 JP2008266250A5 (en) | 2010-04-08 |
JP5069940B2 JP5069940B2 (en) | 2012-11-07 |
Family
ID=40046253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007113743A Active JP5069940B2 (en) | 2007-04-24 | 2007-04-24 | Emulsifier type skin external preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5069940B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015224224A (en) * | 2014-05-28 | 2015-12-14 | 株式会社ヒロマイト | Carbonic acid gas-dissolved oil composition, and application thereof |
JP2016003197A (en) * | 2014-06-16 | 2016-01-12 | 株式会社ヒロマイト | Emulsion composition dissolved with carbon dioxide and application of the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003104860A (en) * | 2001-09-28 | 2003-04-09 | Chifure Keshohin:Kk | Emulsified composition |
JP2003201215A (en) * | 2001-12-28 | 2003-07-18 | Nof Corp | Cleansing cream |
JP2005145872A (en) * | 2003-11-14 | 2005-06-09 | Kao Corp | Sheet-like cleansing material |
JP2006232732A (en) * | 2005-02-25 | 2006-09-07 | Shiseido Co Ltd | Emulsion composition |
JP2006298866A (en) * | 2005-04-25 | 2006-11-02 | Pola Chem Ind Inc | External preparation for cleansing skin |
-
2007
- 2007-04-24 JP JP2007113743A patent/JP5069940B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003104860A (en) * | 2001-09-28 | 2003-04-09 | Chifure Keshohin:Kk | Emulsified composition |
JP2003201215A (en) * | 2001-12-28 | 2003-07-18 | Nof Corp | Cleansing cream |
JP2005145872A (en) * | 2003-11-14 | 2005-06-09 | Kao Corp | Sheet-like cleansing material |
JP2006232732A (en) * | 2005-02-25 | 2006-09-07 | Shiseido Co Ltd | Emulsion composition |
JP2006298866A (en) * | 2005-04-25 | 2006-11-02 | Pola Chem Ind Inc | External preparation for cleansing skin |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015224224A (en) * | 2014-05-28 | 2015-12-14 | 株式会社ヒロマイト | Carbonic acid gas-dissolved oil composition, and application thereof |
JP2016003197A (en) * | 2014-06-16 | 2016-01-12 | 株式会社ヒロマイト | Emulsion composition dissolved with carbon dioxide and application of the same |
Also Published As
Publication number | Publication date |
---|---|
JP5069940B2 (en) | 2012-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007254412A (en) | External preparation for skin for prevention and/or improvement of wrinkles | |
JP2008019230A5 (en) | ||
JP2018008907A (en) | Oil-in-water emulsion cosmetic | |
JP2007230929A (en) | Face wash for removing horny plug | |
JP2013053088A (en) | Powder-containing external skin care preparation | |
JP5057808B2 (en) | Skin external preparation with excellent moisture retention | |
JP5069940B2 (en) | Emulsifier type skin external preparation | |
JP5068091B2 (en) | Emulsifier type skin external preparation | |
JP5368005B2 (en) | Skin external preparation with cleansing function | |
JP5068097B2 (en) | Emulsifier type skin external preparation | |
JP2007191406A5 (en) | ||
JP2007191406A (en) | Emulsifying agent-formed cosmetic | |
TW202308591A (en) | Cosmetic | |
JP2009256255A5 (en) | ||
JP5015468B2 (en) | Skin external preparation suitable for recovery from UV damage | |
JP5068090B2 (en) | Emulsifier type skin external preparation | |
JP4871624B2 (en) | Cosmetics for softening the skin | |
JP5222465B2 (en) | Skin external preparation suitable for esthetics | |
JP2008266250A5 (en) | ||
JP7298885B2 (en) | Skin external liquid preparation, fat reduction agent and slimming agent | |
JP2009256251A (en) | External preparation for skin, suitable as cleansing | |
JP2007161627A (en) | Cleansing oil | |
JP4881040B2 (en) | Gel cosmetic | |
JP2007112767A (en) | Emulsion cosmetic | |
JP2007191407A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100224 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100224 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20100224 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120322 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120327 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120423 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120731 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120820 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20180824 Year of fee payment: 6 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5069940 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |